CRP and lung cancer: Patients in group A (hs-CRP<1 mg/L) were used as control group, and the results of multivariate Cox proportional risk regression model analysis showed that the incidence rates of lung cancer in patients in group B and C were 1.37 and 1.69 times as high as that in patients in group A, respectively (Table 3).